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A B S T R A C T
The goal of the current study was to examine the relationships between insight and both cognitive function and
depression in schizophrenia and schizoaffective disorder, and to determine if there were similar relationships
across diagnostic categories. We examined discrepancies between self and informant reports of function on the
Specific levels of function scale as a metric of insight for interpersonal, social acceptance, work and activities. We
examined two samples of individuals with schizophrenia and/or schizoaffective disorder (Ns of 188 and 67
respectively). In Sample 1, cognition was measured using the Dot Probe Expectancy Task. In Sample 2, cognition
was measured by averaging several subtests from the MATRICS consensus cognitive battery, as well as additional
measures of working memory. In both samples, depression was measured using the Brief Psychiatric Rating
Scale. In both samples, we found significant relationships between worse cognition and overestimations of work
function, as well as between higher depression levels and underestimation of interpersonal function. These
relationships were specific to interpersonal and work function, with significantly stronger correlations with
interpersonal and work function compared to the other areas of function. Similar results were found across
diagnostic categories. These results have important implications for treatment planning, as they suggest the need
to take into account depression and cognitive function when evaluating the patient's self-report of function, and
highlight the utility of informant reports in evaluating function and treatment planning. Further, they add to the
literature on the similarity across schizophrenia and schizoaffective disorder in a variety of pathological
mechanisms.
1. Introduction
Schizophrenia is a debilitating psychiatric disorder associated with
disruptions to work and educational function (Andreasen and Flaum,
1991). One frequent feature of schizophrenia is impairments in insight
(Mintz et al., 2003), defined as awareness of one's psychiatric symptoms
and level of functioning. Impaired insight in schizophrenia has been
linked to higher rates of depression and more impaired cognition
(Bowie et al., 2007), and may make it difficult for individuals with
psychosis to accurately convey to clinicians and psychologists their
level of function and thus to receive the medical and therapeutic
attention that they need (Siu et al., 2015).
Schizophrenia is typically associated with cognitive impairments
(Barch and Ceaser, 2012; Green, 1996; Green et al., 2004a), which in
http://dx.doi.org/10.1016/j.scog.2017.04.001
Received 16 April 2017; Accepted 20 April 2017
⁎ Corresponding author at: Department of Psychological & Brain Sciences; Department of Psychiatry; Department of Radiology, Washington University, Box 1125, One Brookings Drive,
St. Louis, MO 63130, United States.
E-mail addresses: juliaermel@wustl.edu (J. Ermel), cscarter@ucdavis.edu (C.S. Carter), JGOLD@mprc.umaryland.edu (J.M. Gold), angus@umn.edu (A.W. MacDonald),
jdragland@ucdavis.edu (J. Daniel Ragland), steven.silverstein@rutgers.edu (S.M. Silverstein), milton.strauss@gmail.com (M.E. Strauss), dbarch@wustl.edu (D.M. Barch).
Schizophrenia Research: Cognition 9 (2017) 1–7
Available online 09 May 2017
2215-0013/ © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
MARK
turn are associated with lower levels of social and occupational
functioning (Gould et al., 2013). Gilleen and colleagues (Gilleen
et al., 2016) suggested that good cognitive functioning is necessary,
though not sufficient, for good insight into one's level of functioning.
Importantly, individuals with schizophrenia who have poor cognitive
function may overestimate their level of functioning (Bowie et al.,
2007; Nair et al., 2014; Shad et al., 2006; Siu et al., 2015; Stratton et al.,
2013), sometimes even to such an extreme that they will deny having a
mental illness (Bedford and David, 2014).
Many individuals with schizophrenia also experience significant
levels of depression (Avgustin, 2009; Bosanac and Castle, 2013), which
is related to insight (Ampalam et al., 2012; Bowie et al., 2007;
Gharabawi et al., 2007; Palmer et al., 2015). An extensive literature
suggests that depressed people have a more realistic view, albeit often
more negative, of themselves than non-depressed people (Soderstrom
et al., 2011). This idea is termed “depressive realism” (Alloy and
Abramson, 1979, 1988). An additional perspective is that patients who
can comprehend more about how their illness negatively affects them
(i.e., who have greater insight) become more depressed (Misdrahi et al.,
2014; Palmer et al., 2015), a relationship termed the “insight paradox.”
Both of these theories would suggest that depressed individuals with
psychosis should have better insight. However, depression can also be
associated with high levels of self-blaming and feelings of inadequacy
and hopelessness (Zahn et al., 2015). Thus, depression may lead the
individual to under estimate their level of function. Recent work by
Harvey and colleagues is more consistent with the depressive realism or
insight paradox hypotheses, showing that individuals with schizophre-
nia and schizoaffective disorder who were higher in self-reported
depression were more accurate reporters as to their interpersonal,
everyday activity, and vocational function (Harvey et al., 2016).
One important question not yet clearly addressed in the prior
literature is the degree to which the relationships among insight,
depression and cognition are similar among putatively different diag-
nostic categories among the schizophrenia spectrum disorders, such as
schizophrenia versus schizoaffective disorder. There is some evidence
that insight may be more intact among individuals with schizoaffective
disorder versus schizophrenia (Birindelli et al., 2014; Wiffen et al.,
2010), though recent work by Harvey and colleagues did not see
evidence for greater insight among individuals with schizoaffective
disorder (Harvey et al., 2016). There is also evidence for higher
depression levels in schizoaffective disorder (e.g., Birindelli et al.,
2014; Harvey et al., 2016; Woodberry et al., 2008). However, the level
of cognitive impairment is similar across schizophrenia and schizoaf-
fective disorder (Bora et al., 2009; Fiszdon et al., 2007; Owoso et al.,
2013; Reichenberg et al., 2009). Several previous studies included both
individuals with schizophrenia and schizoaffective disorder, and some
studies explicitly controlled for diagnosis when examining such rela-
tionships (Onwuameze et al., 2016). However, no study has yet directly
compared the magnitude of these interrelationships across schizophre-
nia and schizoaffective disorder.
Our goal was to examine the relationships between insight and both
cognitive function and depression in both schizophrenia and schizoaf-
fective disorder. We used the discrepancies between self and a knowl-
edgeable informant's report of function on the Specific Levels of
Function (SLOF) scale as a metric of insight (Bowie et al., 2007;
Corriveau and Sousa, 2013). We predicted that individuals with
psychosis with more severe cognitive impairment would over-estimate
their level of function (Bowie et al., 2007). Further, we wished to
determine whether depression in schizophrenia would be associated
with greater insight or with impaired insight. If impaired, we predicted
that greater depression would lead patients to under-estimate their level
of function (Siu et al., 2015). Lastly, we asked whether there were any
significant differences between individuals with schizophrenia and
schizoaffective disorder in these relationships.
2. Materials and methods
2.1. Participants
Participant data were taken from several samples recruited by the
Cognitive Neuroscience Test Reliability and Clinical Applications for
Schizophrenia Consortium (CNTRACS). The recruitment, assessment
and inclusion/exclusion procedures both Sample 1 (a combination of
two studies) (Henderson et al., 2012) (Strauss et al., 2013) and Sample
2 (Barch et al., 2017) are described in Supplemental materials. We
examined only those participants who had informant rated functional
status. This resulted in a total of 188 individuals with schizophrenia
(N= 138) or schizoaffective disorder (N= 50) in Sample 1 and 67 in
Sample 2 (35 schizophrenia, 32 schizoaffective).
2.2. Specific levels of functioning scale
The specific levels of functioning (SLOF) scale assess the level of
functioning on four different subscales: interpersonal, social accep-
tance, activities, and work. Participants completed the SLOF during one
of their testing sessions and provided the name of a knowledgeable
informant. Study staff then either conducted a phone interview to
obtain informant SLOF scores, or sent the informant a paper version
with a stamped return envelope. The informant received $10 for
completing the SLOF. We used the difference between self and
informant SLOF reports as a proxy for insight (Figs. S1-S4 for
histograms). A positive value meant that the patient rated themselves
as doing better than the informant rated them. A negative value meant
that the patient rated themselves as doing worse than the informant
rated them.
2.3. Cognitive tasks
In Sample 1, the Dot Probe Expectancy (DPX) task was used to
assess cognitive function, as described in (Henderson et al., 2012) and
in Supplemental materials. The testing for Sample 2 did not include the
DPX. Thus, instead we created an average cognition variable by
combining the following tasks: 1) three subtests of the MATRICs
consensus cognitive battery (Digit Symbol, Hopkins Verbal Learning
(HVLT), and letter number sequencing (LNS)(Green et al., 2004b; Kern
et al., 2008); 2) two versions of a running span working memory task
(Broadway and Engle, 2010) (Supplemental materials); 3) two versions of
a change detection working memory task (Supplemental materials); and
4) two versions of a change localization working memory task (Supple-
mental materials)(Gold et al., 2010; Gold et al., 2003). We z-scored
(using the patient data) the primary dependent variable from each task
and averaged them. This approach meant that we used different
measures of cognition across samples, but provides greater evidence
for generalizability across samples.
2.4. Diagnosis and clinical assessment
Diagnostic assessments were conducted or supervised by a master's
level clinician using the Structured Clinical Interview for DSM-IV-Text
Revision and the 24-item Brief Psychiatric Rating Scale (First et al.,
2002; Ventura et al., 1993a; Ventura et al., 1993b). See Supplemental
materials for details. We focused on the BPRS depression subscale (items
2, 3, 4 and 5; anxiety, depression, suicidality, and guilt) (Ventura et al.,
1993b), but examined positive, negative, and disorganized symptoms as
potential confounders in Supplemental materials.
2.5. Data processing and statistical analyses
We first examined the correlations between individual self-infor-
mant SLOF report discrepancy scores and BPRS depression and cogni-
tion measures separately for Samples 1 and 2. We used False Discovery
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Rate (FDR) to correct for the false positive rate (Benjamini and
Yekutieli, 1995, 2001). To better understand the source of the effects,
we converted the dimensional scores into groups of over-estimators
(+0.5 SD for the discrepancy score and greater), under-estimators
(−0.5 SD for the discrepancy score and lower) and accurate estimators
(within +− 0.5 SD). This analysis was meant to characterize the
pattern established by the primary dimensional analyses. To do so, we
combined the two samples by Z-scoring all of the variables within each
patient sample, as the number of participants in Sample 2 would lead to
small Ns within subgroups. We used this combined sample to create the
“groups” described above and to compare schizophrenia to schizoaffec-
tive disorder, so as to maximize power. We conducted regression
analyses with diagnostic group, the discrepancy score, and the interac-
tion between diagnosis and discrepancy score to predict either depres-
sion or cognition. In the Supplemental materials we report on analyses
using residualized change scores to assess the relative contributions of
self- versus informant-reports, as well as potential demographic or
clinical confounders.
3. Results
3.1. Sample 1
As shown in Table 1, performance on the DPX was significantly
correlated with the work discrepancy score, which survived FDR
correction. Further, using tests to compare dependent correlations
(Meng et al., 1992), the work discrepancy score was significantly more
correlated with DPX performance than the social acceptance
(Z =−3.07, p < 0.001), interpersonal (Z =−2.28, p= 0.011),
and activities (Z =−3.27, p= 0.002) discrepancy scores. As shown
in Fig. 1a, worse cognitive function was associated with the individual
rating themselves as having better work function than they were rated
by the informant.
BPRS depression was significantly correlated with the discrepancy
scores for work and interpersonal function (Table 1), both of which
survived FDR correction, but not with the scores for activities or social
acceptance. Greater depression was associated with the individual
rating themselves as having worse interpersonal function than they
were rated by the informant (Fig. 1b). Interpersonal discrepancy scores
were significantly more correlated with BPRS depression than both the
social acceptance (Z =−2.80, p= 0.002) and activities discrepancy
scores (Z =−1.92, p= 0.027), and the work discrepancy score was
significantly more correlated with BPRS depression than the social
acceptance discrepancy score (Z =−1.87, p= 0.03).
3.2. Sample 2
In Sample 2, cognition was again negatively associated with both
work and interpersonal discrepancy scores (Table 1 and Fig. 1c). These
correlations also survived FDR correction (Table 1). For Sample 2, BPRS
depression scores were again significantly associated with the inter-
personal discrepancy score (Table 1 and Fig. 1d), a relationship that
survived FDR correction. However, we did not see a significant
correlation between BPRS depression and the work discrepancy score
in Sample 2, though Fisher's r to Z transform analyses did not indicate a
significant difference in the magnitude of the correlations across the
two samples (rs of −0.18 versus −0.13 respectively, Z = 0.35,
p = 0.36).
3.3. Categorical analysis
To better understand the nature of these associations, we examined
relationships of the categorical self vs. informant groupings to the
cognitive measures and BPRS depression. For the work discrepancy
score groups, there were 71 over-estimators, 90 correct estimators, and
94 under-estimators. For the interpersonal discrepancy score groups,
there were 81 over-estimators, 97 correct estimators and 77 under-
estimators. For the work discrepancy score groups, there was a
significant effect for cognition (F(2252) = 7.23, p= 0.001), but not
for depression (F(2252) = 0.46, p= 0.63). As shown in Fig. 2a, post-
hoc contrasts indicated that over-estimators had worse cognition scores
than under-estimators (Cohen's D = 0.58, p < 0.001), with a trend to
also have worse cognition than the correct estimators (Cohen's
D = 0.27, p= 0.078). The correct estimators also had worse cognition
than the under-estimators (Cohen's D = 0.30, p= 0.03). For the
interpersonal discrepancy score groups (Fig. 2b), there was a significant
effect for depression (F(2252) = 5.92, p= 0.003), but not for cognition
(F(2252) = 2.36, p= 0.097). As shown in Fig. 2, posthoc contrasts
indicated that under-estimators had higher depression scores than over-
estimators (Cohen's D = 0.53, p= 0.001), but did not differ signifi-
cantly from correct-estimators (Cohen's D = 0.23, p= 0.12). Correct
estimators had greater depression than over-estimators (Cohen's
D = 0.30, p= 0.042).
3.4. Schizophrenia versus schizoaffective disorder
The diagnostic groups did not differ in age, gender, personal
education, parental education, or cognitive function (Table 2). The
individuals with schizoaffective disorder had higher BPRS depression
and lower disorganization symptoms than those with schizophrenia,
but did not differ in positive or negative symptoms (Table 2). The
groups differed in both the interpersonal and work discrepancy scores,
with more positive values in schizophrenia. The regression using the
work discrepancy score to predict cognition indicated a main effect of
work score (t =−4.22, β=−0.27, p < 0.001), but no main effect of
diagnosis (t =−0.94, β=−0.06, p= 0.35), or interaction between
diagnosis and work score (t =−0.51, β=−0.03, p= 0.61). Follow
up correlations indicated that the work score and cognition were
significantly correlated in both schizophrenia (r=−0.23, p= 0.002)
and schizoaffective disorder (r=−0.31, p= 0.005). The regression
using the interpersonal discrepancy score to predict BPRS depression
also indicated a main effect of interpersonal score (t =−2.76,
β=−0.20, p= 0.006), but no main effect of diagnosis (t = 0.61,
β= 0.04, p= 0.54), or interaction (t = 0.44, β= 0.03, p= 0.66).
Table 1
Relationships between self-other discrepancy scores and depression and cognition.
Activities discrepancy score Interpersonal discrepancy score Social acceptance discrepancy score Work discrepancy score
Variable r p r p r p r p
Sample 1
BPRS depression −0.13 0.08 −0.28 < 0.001 −0.003 0.97 −0.18 0.013
DPX 0.02 0.82 −0.08 0.26 0.04 0.56 −0.25 < 0.001
Sample 2
BPRS depression 0.15 0.11 −0.31 0.005 −0.007 0.48 −0.13 0.16
Cognition composite −0.03 0.42 −0.24 0.025 −0.07 0.30 −0.26 0.016
*p < 0.05, **p < 0.01.
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Follow up correlations indicated that the interpersonal score and
cognition were significantly correlated in schizophrenia (r=−0.24,
p= 0.001) but not schizoaffective disorder (r=−0.14, p= 0.22).
4. Discussion
The current study found a significant relationship between cogni-
tion and the discrepancy in self versus informant reports of work
function for two independent samples, such that individuals who
Fig. 1. A) Relationship between work discrepancy score and DPX D′-context in Sample 1; B) Relationship between interpersonal discrepancy score and BPRS depression in Sample 1; C)
Relationship between work discrepancy score and DPX D′-context in Sample 2; D) Relationship between interpersonal discrepancy score and BPRS depression in Sample 2.
Fig. 2. A) Graph illustrating the relationships of depression and cognitive function to groups defined by the magnitude of the self-informant interpersonal discrepancy score; B) Graph
illustrating the relationships of depression and cognitive function to groups defined by the magnitude of the self-informant work discrepancy score.
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overestimated their work function had more impaired cognition. These
findings are consistent with prior work that also found that patients
who over-estimate their level of functioning tend to have lower levels of
cognition (Siu et al., 2015). We found that the relationships between
cognition and insight about work function was signifciantly stronger
than the relationship between cognition and insight in regards to
interpersonal, social acceptance or community activities. This suggests
that cognitive function is particularly critical for a patient's under-
standing of their occupational or academic capabilities. However, as
shown in supplemental analyses, we also found that the the magnitude
of the discrepancy itself may not be as strongly related to cognition as
the informant report itself when assessed using residualized change
scores that are less dependent on baseline scores. This finding high-
lights the need for informant reports to evaluate work function levels in
schizophrenia.
In both samples, higher depressive symptoms were significantly
related to patients under-estimating their interpersonal function. The
finding of a significant relationship between depression and under-
estimating one's interpersonal function is consistent with prior work in
schizophrenia (Palmer et al., 2015) and with prior work showing that
people with depressive symptoms often have a negative self-bias (Zahn
et al., 2015). Further, we found that although depression levels were
related to the patient's own report of interpersonal function, the
discrepancy scores continued to relate to depression even when we
used residualized change scores, as described in supplemental analyses.
This finding suggests that depression is related to the actual magnitude
of the discrepancy between informant- and self-report, as well as to the
patient's self-evaluation of their interpersonal function. Our findings
differ somewhat from those of Harvey and colleagues, who found that
greater depression in psychotic individuals was associated with more
accurate self-assessment, but did not find evidence for underestimation
of function in the most depressed individuals (Harvey et al., 2016). It is
possible that the differences across these studies are related to the
method of depression assessment. Harvey and colleagues used self-
report on the Beck Depression Inventory, while we used clinician
ratings on the Brief Psychiatric Rating Scale. It would be important in
future work to collect both types of assessment in the same individuals
to determine whether they show differential relationships to insight.
As has been seen in some prior work (Birindelli et al., 2014; Wiffen
et al., 2010), though not all (Harvey et al., 2016), we found that
individuals with schizophrenia and schizoaffective disorder had differ-
ent levels of insight. On average, there were no significant differences in
the self-versus informant report for either interpersonal or work
function in schizophrenia. However, the individuals with schizoaffec-
tive disorder provided significantly lower evaluations of their inter-
personal function compared to informant. Further, the individuals with
schizoaffective disorder had higher depression levels than the indivi-
duals with schizophrenia, consistent with prior work (e.g., Birindelli
et al., 2014; Woodberry et al., 2008). However, the two diagnostic
groups did not differ in cognitive function, again consistent with prior
work (Bora et al., 2009; Fiszdon et al., 2007; Owoso et al., 2013;
Reichenberg et al., 2009). Importantly, the relationships between the
interpersonal discrepancy score and depression did not differ as a
function of diagnostic group and were significant in each group
independently. There was a significant correlation between the inter-
personal discrepancy score and BPRS depression in schizophrenia, and
this correlation was in the same direction in the schizoaffective group,
though not significant. These results add to the literature suggesting
that both schizophrenia and schizoaffective disorder should be con-
sidered on the same continuum of psychosis, and point to the
interrelationship across insight, depression, and cognitive function
across diagnostic categories.
4.1. Limitations and future directions
Our participants were medicated and it would be important in
future work to understand whether medication status influenced the
relationship between self and informant reported function. In addition,
this study was cross-sectional and thus we could not address the causal
relationship between either depression and cognition and insight. It will
also be important to determine whether we see similar findings in other
clinical groups to determine if these relationships are unique to
psychosis. Lastly, asking more than one informant may provide an
even a better representation of the patient's level of function. However,
it can be difficult to engage even one informant, making the use of
multiple informants challenging.
5. Conclusion
The current study provides further evidence that both depression
and cognitive function are related to insight in schizophrenia, as
measured by discrepancies between self and informant reports.
Importantly, both of these findings replicated across two independent
samples and across schizophrenia and schizoaffective disorder. These
results suggest that a patient's level of cognitive function should be
considered when evaluating their reports of occupational or academic
function, or in when evaluating the feasibility of successfully starting
new occupational pursuits. They also suggest that depression level
should be considered when evaluating a patient's report of interperso-
nal function. These results also suggest that it may be particularly
important to obtain an informant's perspective on the patient's function
when they either have low levels of cognitive function or high levels of
depression to most realistically evaluate what they are capable of and
when they may need further support or intervention.
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